Home/Filings/4/0001209191-21-024238
4//SEC Filing

SR One Capital Fund I Aggregator LP 4

Accession 0001209191-21-024238

CIK 0001807120other

Filed

Mar 31, 8:00 PM ET

Accepted

Apr 1, 6:23 PM ET

Size

17.2 KB

Accession

0001209191-21-024238

Insider Transaction Report

Form 4
Period: 2021-03-30
Transactions
  • Conversion

    Common Stock

    2021-03-30+4,439,8394,439,839 total
  • Conversion

    Common Stock

    2021-03-30+936,6375,376,476 total
  • Purchase

    Common Stock

    2021-03-30$20.00/sh+250,000$5,000,0005,626,476 total
  • Conversion

    Series A Preferred Stock

    2021-03-307,236,9380 total
    Common Stock (4,439,839 underlying)
  • Conversion

    Series B Preferred Stock

    2021-03-301,526,7180 total
    Common Stock (936,637 underlying)
Transactions
  • Conversion

    Common Stock

    2021-03-30+936,6375,376,476 total
  • Conversion

    Series A Preferred Stock

    2021-03-307,236,9380 total
    Common Stock (4,439,839 underlying)
  • Conversion

    Common Stock

    2021-03-30+4,439,8394,439,839 total
  • Conversion

    Series B Preferred Stock

    2021-03-301,526,7180 total
    Common Stock (936,637 underlying)
  • Purchase

    Common Stock

    2021-03-30$20.00/sh+250,000$5,000,0005,626,476 total
Transactions
  • Conversion

    Common Stock

    2021-03-30+4,439,8394,439,839 total
  • Conversion

    Common Stock

    2021-03-30+936,6375,376,476 total
  • Purchase

    Common Stock

    2021-03-30$20.00/sh+250,000$5,000,0005,626,476 total
  • Conversion

    Series A Preferred Stock

    2021-03-307,236,9380 total
    Common Stock (4,439,839 underlying)
  • Conversion

    Series B Preferred Stock

    2021-03-301,526,7180 total
    Common Stock (936,637 underlying)
Footnotes (3)
  • [F1]The Series A Preferred Stock and the Series B Preferred Stock were converted into Common Stock on a 1.63-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock and Series B Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
  • [F2]The reported securities are held directly by SR One Capital Fund I Aggregator, LP. SR One Capital Partners I, LP is the general partner of SR One Capital Fund I Aggregator, LP, and SR One Capital Management, LLC is the general partner of SR One Capital Partners I, LP. Simeon George, M.D. is the managing member of SR One Capital Management, LLC. Each of SR One Capital Partners I, LP, SR One Capital Management, LLC and Mr. George may each be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
  • [F3]SR One Capital Fund I Aggregator, LP purchased 250,000 shares of Common Stock of Design Therapeutics, Inc. (the "Issuer") in connection with the Issuer's public offering.

Issuer

Design Therapeutics, Inc.

CIK 0001807120

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001848319

Filing Metadata

Form type
4
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 6:23 PM ET
Size
17.2 KB